LXEO Operating Cash Flow (Statement)

Lexeo Therapeutics Inc · Operating Cash Flow (Statement)

LXEO logo

LXEO Operating Cash Flow (Statement)

Latest reported-$88.37M
LXEO Cash from Operations (-$3.13M → -$88.37M)
High-resolution chart · PNG

LXEO operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lexeo Therapeutics Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-98,561,000
-81,151,000
-59,496,000
-54,560,000
-44,182,000
-3,133,396
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.